Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5

NCT00652002 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: budesonide/formoterol
DRUG: budesonide
DRUG: formoterol

Sponsor

AstraZeneca